109 related articles for article (PubMed ID: 10750985)
21. Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment.
Caglar M; Tuncel M; Alpar R
Clin Nucl Med; 2002 Nov; 27(11):767-71. PubMed ID: 12394122
[TBL] [Abstract][Full Text] [Related]
22. Radioprotection of salivary glands by amifostine in high-dose radioiodine treatment. Results of a double-blinded, placebo-controlled study in patients with differentiated thyroid cancer.
Bohuslavizki KH; Klutmann S; Brenner W; Kröger S; Buchert R; Bleckmann C; Mester J; Henze E; Clausen M
Strahlenther Onkol; 1999 Nov; 175 Suppl 4():6-12. PubMed ID: 10584133
[TBL] [Abstract][Full Text] [Related]
23. Postoperative uptake in the thyroid bed, not tumor stage, determines the usefulness of diagnostic whole body scan in the first year after ablation with radioiodine.
Rosário PW; Barroso AL; Purisch S
Thyroid; 2007 Aug; 17(8):803-4. PubMed ID: 17708716
[No Abstract] [Full Text] [Related]
24. Progressive changes in the major salivary gland after radioiodine therapy for differentiated thyroid cancer: a single-center retrospective ultrasound cohort study.
Huang Z; Chen Y; Pan L; Feng H; Wu J; Chen P; Wang J; Ouyang W
Ultrasound Med Biol; 2021 Sep; 47(9):2514-2522. PubMed ID: 34147311
[TBL] [Abstract][Full Text] [Related]
25. Stunning after tracer dosimetry.
Diehl M; Grünwald F
J Nucl Med; 2001 Jul; 42(7):1129. PubMed ID: 11438639
[No Abstract] [Full Text] [Related]
26. Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer.
Almeida JP; Sanabria AE; Lima EN; Kowalski LP
Head Neck; 2011 May; 33(5):686-90. PubMed ID: 21484917
[TBL] [Abstract][Full Text] [Related]
27. Spurious metastasis on whole body scans in a patient with thyroid carcinoma.
Bajramovic S; DeGroot LJ
J Endocrinol Invest; 1998 Sep; 21(8):541-3. PubMed ID: 9801997
[TBL] [Abstract][Full Text] [Related]
28. Thyroid stunning.
Coakley AJ
Eur J Nucl Med; 1998 Mar; 25(3):203-4. PubMed ID: 9580850
[No Abstract] [Full Text] [Related]
29. What is the best strategy to treat and study patients after near-total thyroidectomy?
Sarmiento AJ; Sarmiento FM; Sarmiento AH
J Nucl Med; 2001 Mar; 42(3):531-3. PubMed ID: 11337535
[No Abstract] [Full Text] [Related]
30. A patient with asymmetric parotid uptake on a diagnostic iodine-131 scan during thyroid cancer follow-up.
Frew J; Mallick U; Perros P
Thyroid; 2007 Aug; 17(8):801-2. PubMed ID: 17725441
[No Abstract] [Full Text] [Related]
31. Iodine kinetics and dosimetry in the salivary glands during repeated courses of radioiodine therapy for thyroid cancer.
Liu B; Huang R; Kuang A; Zhao Z; Zeng Y; Wang J; Tian R
Med Phys; 2011 Oct; 38(10):5412-9. PubMed ID: 21992360
[TBL] [Abstract][Full Text] [Related]
32. Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy.
Solans R; Bosch JA; Galofré P; Porta F; Roselló J; Selva-O'Callagan A; Vilardell M
J Nucl Med; 2001 May; 42(5):738-43. PubMed ID: 11337569
[TBL] [Abstract][Full Text] [Related]
33. Sialadenitis mimicking metastatic thyroid carcinoma.
Kolla IS; Alazraki NP; Watts NB
Clin Nucl Med; 1989 Aug; 14(8):564-6. PubMed ID: 2805535
[TBL] [Abstract][Full Text] [Related]
34. [Salivary gland scintigraphy after radio-iodine therapy. Functional scintigraphy of the salivary gland after high dose radio-iodine therapy (author's transl)].
Albrecht HH; Creutzig H
Rofo; 1976 Dec; 125(6):546-51. PubMed ID: 137852
[TBL] [Abstract][Full Text] [Related]
35. Should high hTg levels in the absence of iodine uptake be treated?
Britton KE; Foley RR; Chew SL
Eur J Nucl Med Mol Imaging; 2003 May; 30(5):794-5. PubMed ID: 12616324
[No Abstract] [Full Text] [Related]
36. Radioiodine and thyroid cancer: some questions, controversies, and considerations.
Daniels GH
Endocr Pract; 2001; 7(4):320-3. PubMed ID: 11497485
[No Abstract] [Full Text] [Related]
37. Diagnostic I-123 scintigraphy to assess potential breast uptake of I-131 before radioiodine therapy in a postpartum woman with thyroid cancer.
Hsiao E; Huynh T; Mansberg R; Bautovich G; Roach P
Clin Nucl Med; 2004 Aug; 29(8):498-501. PubMed ID: 15249829
[No Abstract] [Full Text] [Related]
38. Partial stunning in thyroid remnant after administration of scanning dose followed by 100 mCi I-131 therapy.
Yagcloglu H; Ozalp E; Ibis E; Aras G
Clin Nucl Med; 1996 Apr; 21(4):340. PubMed ID: 8925630
[No Abstract] [Full Text] [Related]
39. Scintigraphic control of radioiodine 131-I distribution following administration of therapeutic dose for a differentiated cancer of the thyroid gland.
Röhling S; Nĕmec J; Zamrazil V; Pohunková D; Jezek V
Czech Med; 1983; 6(2):125-6. PubMed ID: 6409563
[No Abstract] [Full Text] [Related]
40. [Role of the nuclear medicine in the treatment of thyroid carcinoma].
Börner W; Reiners C
Med Klin; 1980 Jan; 75(2):80-7. PubMed ID: 7374606
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
